SMMT

Summit Therapeutics
D

SMMT

15.440
USD
0.31
(2.02%)
مفتوح الان
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
117,730
الربح لكل سهم
-1
العائد الربحي
-
P/E
-14
حجم السوق
12,317,253,855
أصول ذات صلة

العنوان: Summit Therapeutics

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate isridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.